Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma

• Status: Unknown status
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the use of magnesium sulfate nebulization in patient with moderate to severe asthma exacerbation in pediatric emergency.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hamad Medical Corporation
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• Pediatric asthma patients with moderate to severe exacerbation

Exclusion Criteria:

• Known allergy to magnesium sulfate

• History of neuromuscular disease, cardiac disease, renal disease, or underlying chronic lung disease

• Use of oral steroid medication within 72 hours of presentation

• Radiographic evidence of pneumonia at presentation

• Administration of intravenous magnesium sulfate prior to study enrollment